Cargando…

Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva

BACKGROUND: Increased formation of reactive oxygen species may be caused by the ion release of the metal alloys used in prosthetic dental restorations due to the corrosion process. As products of lipid peroxidation, isoprostanes can be used as a marker for oxidative stress in the body. There are two...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomova, Zlatina, Tomov, Desislav, Vlahova, Angelina, Chaova-Gizdakova, Veneta, Yoanidu, Lyubka, Svinarov, Dobrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618336/
https://www.ncbi.nlm.nih.gov/pubmed/36381076
http://dx.doi.org/10.5937/jomb0-33556
_version_ 1784821028105486336
author Tomova, Zlatina
Tomov, Desislav
Vlahova, Angelina
Chaova-Gizdakova, Veneta
Yoanidu, Lyubka
Svinarov, Dobrin
author_facet Tomova, Zlatina
Tomov, Desislav
Vlahova, Angelina
Chaova-Gizdakova, Veneta
Yoanidu, Lyubka
Svinarov, Dobrin
author_sort Tomova, Zlatina
collection PubMed
description BACKGROUND: Increased formation of reactive oxygen species may be caused by the ion release of the metal alloys used in prosthetic dental restorations due to the corrosion process. As products of lipid peroxidation, isoprostanes can be used as a marker for oxidative stress in the body. There are two significant advantages of using isoprostanes as an oxidative stress marker - presence in all fluids in the body and low reactivity. Saliva provides noninvasive, painless, and cost-effective sample collection and can be used as an alternative testing medium of blood and urine. METHODS: This study presents the development and validation of a sample LC-MS/MS method to quantify 8-isoprostaglandin F2-a in human saliva using salt-out assisted liquid-liquid extraction (SALLE). RESULTS: The selected sample preparation procedure optimized chromatographic separation and mass detection provided high recovery and sensitivity of the analysis. The calibration curve was obtained in the predefined range 25-329 ng/L with R2 larger than 0.995. Normalized matrix varied between 89.7 % and 113.5%. The method showed sufficient accuracy and precision - accuracy in the range 89.7 %-113.9 %, and precision between 2.3% and 5.4%. CONCLUSIONS: The proposed method is validated according to current EMA/FDA industrial guidance for bioanalysis and offers an appropriate level of sensitivity and sufficient accuracy and precision.
format Online
Article
Text
id pubmed-9618336
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format MEDLINE/PubMed
spelling pubmed-96183362022-11-14 Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva Tomova, Zlatina Tomov, Desislav Vlahova, Angelina Chaova-Gizdakova, Veneta Yoanidu, Lyubka Svinarov, Dobrin J Med Biochem Original Paper BACKGROUND: Increased formation of reactive oxygen species may be caused by the ion release of the metal alloys used in prosthetic dental restorations due to the corrosion process. As products of lipid peroxidation, isoprostanes can be used as a marker for oxidative stress in the body. There are two significant advantages of using isoprostanes as an oxidative stress marker - presence in all fluids in the body and low reactivity. Saliva provides noninvasive, painless, and cost-effective sample collection and can be used as an alternative testing medium of blood and urine. METHODS: This study presents the development and validation of a sample LC-MS/MS method to quantify 8-isoprostaglandin F2-a in human saliva using salt-out assisted liquid-liquid extraction (SALLE). RESULTS: The selected sample preparation procedure optimized chromatographic separation and mass detection provided high recovery and sensitivity of the analysis. The calibration curve was obtained in the predefined range 25-329 ng/L with R2 larger than 0.995. Normalized matrix varied between 89.7 % and 113.5%. The method showed sufficient accuracy and precision - accuracy in the range 89.7 %-113.9 %, and precision between 2.3% and 5.4%. CONCLUSIONS: The proposed method is validated according to current EMA/FDA industrial guidance for bioanalysis and offers an appropriate level of sensitivity and sufficient accuracy and precision. Society of Medical Biochemists of Serbia, Belgrade 2022-10-15 2022-10-15 /pmc/articles/PMC9618336/ /pubmed/36381076 http://dx.doi.org/10.5937/jomb0-33556 Text en 2022 Zlatina Tomova, Desislav Tomov, Angelina Vlahova, Veneta Chaova-Gizdakova, Lyubka Yoanidu, Dobrin Svinarov, published by CEON/CEES https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License.
spellingShingle Original Paper
Tomova, Zlatina
Tomov, Desislav
Vlahova, Angelina
Chaova-Gizdakova, Veneta
Yoanidu, Lyubka
Svinarov, Dobrin
Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva
title Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva
title_full Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva
title_fullStr Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva
title_full_unstemmed Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva
title_short Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva
title_sort development and validation of an lc-ms/ms method for determination of 8-iso-prostaglandin f2 alpha in human saliva
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618336/
https://www.ncbi.nlm.nih.gov/pubmed/36381076
http://dx.doi.org/10.5937/jomb0-33556
work_keys_str_mv AT tomovazlatina developmentandvalidationofanlcmsmsmethodfordeterminationof8isoprostaglandinf2alphainhumansaliva
AT tomovdesislav developmentandvalidationofanlcmsmsmethodfordeterminationof8isoprostaglandinf2alphainhumansaliva
AT vlahovaangelina developmentandvalidationofanlcmsmsmethodfordeterminationof8isoprostaglandinf2alphainhumansaliva
AT chaovagizdakovaveneta developmentandvalidationofanlcmsmsmethodfordeterminationof8isoprostaglandinf2alphainhumansaliva
AT yoanidulyubka developmentandvalidationofanlcmsmsmethodfordeterminationof8isoprostaglandinf2alphainhumansaliva
AT svinarovdobrin developmentandvalidationofanlcmsmsmethodfordeterminationof8isoprostaglandinf2alphainhumansaliva